TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization Clinical Trials
2 recruitingRadiation
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma
Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma
University of Miami30 enrolled1 locationNCT06902246
Recruiting
Phase 2
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
Metastatic Uveal MelanomaMetastatic Uveal Melanoma in the Liver
University of Miami30 enrolled1 locationNCT06627244